| 08:00–08:45 | Meet the Expert Sessions 6–10 | |
| 08:00 | M06 | Hematology—hematopoietic stem cell transplantation |
| Nikolai Klimko, FECMM, Russia & Tony Pagliuca, UK | ||
| 08:00 | M07 | Molecular Diagnostics |
| Maurizio Sanguinetti, Italy & Dieter Buchheidt, FECMM, Germany | ||
| 08:00 | M08 | Surgery/Transplantation |
| Patricia Munoz, Spain & Paolo Grossi, Italy | ||
| 08:00 | M09 | Neonates |
| Thomas Walsh, FECMM, USA & Emmanuel Roilides, FECMM, Greece | ||
| 08:00 | M10 | Meet Mr. and Mrs. Fungus |
| Cornelia Lass-Flörl, FECMM, Austria & Neil Gow, FECMM, UK | ||
| 08:50–09:50 | Plenary Session 4—Top 10 papers in Mycology | |
| Chairs: Maiken Arendrup, Denmark & Malcolm Richardson, FECMM, UK | ||
| 08:50 | PS4.1 | The Clinical and Translational Perspective |
| Don Sheppard, FECMM, Canada | ||
| 09:20 | PS4.2 | The Microbiology Perspective |
| Katrien Lagrou, FECMM, Belgium | ||
| ECMM Academy and Excellence Centers: A Story of Success | ||
| Chair: Martin Hoenigl, FECMM, Austria | ||
| 09:50 | ECMM Academy | |
| Katrien Lagrou, FECMM, Belgium | ||
| 09:55 | ECMM Excellence Centers | |
| Cornelia Lass-Flörl, FECMM, Austria | ||
| 10:30–11:30 | Plenary Session 5—ICU—Candida Infections/Breaking News from Hematology and ICU | |
| Chairs: Johan Maertens, FECMM, Belgium / Maricela Valerio, Spain | ||
| 10:30 | PS5.1 | Abdominal Candidiasis in ICU Patients |
| Philipp Köhler, FECMM, Germany | ||
| 10:45 | PS5.2 | Are the New Management Strategies Useful? |
| Arnaldo Colombo, FECMM, Brazil | ||
| 11:00 | PS5.3 | CNS Infections |
| Anna Candoni, Italy | ||
| 11:15 | PS5.4 | CMV and Aspergillosis in HSCT Patients |
| Johan Maertens, FECMM, Belgium | ||
| 11:30–12:30 | Poster Session 2 | |
| 11:30 | Video Session | |
| 11:30 | V01 | Subcutaneous Nodule Caused by Phaeoacremonium fuscum in a Non-Immunocompromised Patient |
| Sofie Colman, Belgium | ||
| 11:40 | V02 | Trichosporon Diagnosis—The Right Path |
| Thayanidhi Premamalini, India | ||
| 11:50 | V03 | Disseminated Rhinosporidiosis with Different Morphological Lesions Involving Various Anatomical Sites |
| Jagdish Chander, India | ||
| 14:15–15:45 | Parallel Symposia 15–19 | |
| Symposium 15 | Aspergillus in the ICU | |
| Chairs: Katrien Lagrou, FECMM, Belgium & Alessandro Pasqualotto, FECMM, Brazil | ||
| 14:15 | S15.1 | Influenza |
| Joost Wauters, Belgium | ||
| 14:35 | S15.2 | Invasive Aspergillosis in Patients with Underlying Liver Cirrhosis |
| Juergen Prattes, Austria | ||
| 14:55 | S15.3 | Renal Failure |
| Riina Richardson Rautema, FECMM, UK | ||
| 15:15 | S15.4* | Fungal Pneumonia in Critically Ill Cirrhotics: Spectrum, Outcomes, Comparison of Diagnostic Methods and Biomarkers |
| Pratibha Kale, India | ||
| 15:25 | S15.5* | IPAFLU Survey: Invasive Aspergillosis among Patients with Severe Influenza in Intensive Care Units |
| Joost Wauters, Belgium | ||
| 15:35 | S15.6* | Trend of Candidemia with Bloodstream Infection in Intensive Care Units from 2006 to 2017: Results from the Korean National Healthcare-Associated Infections Surveillance System |
| Young Hwa Choi, Korea | ||
| Symposium 16 | Dermatology | |
| Chairs: Valentina Arsic Arsenijevic, ECMM, Serbia & Sevtap Arıkan Akdagli, FECMM, Turkey | ||
| 14:15 | S16.1 | Cutaneous Aspergillosis, Is It So Rare? |
| Sevtap Arıkan Akdagli, FECMM, Turkey | ||
| 14:35 | S16.2 | Is Resistance a Problem for Dermatophytosis? |
| Pietro Nenoff, Germany | ||
| 14:55 | S16.3 | Phaeohyphomycosis |
| Teresa Martin, Spain | ||
| 15:15 | S16.4 | Blastomycosis |
| Ilan Schwarz, Canada | ||
| 15:35 | S16.5* | Galleria mellonella as a Novelty Model to Study Host—Pathogen Interaction in Malassezia furfur CBS 1878 |
| Adriana Marcela Celis Ramírez, Colombia | ||
| Symposium 17 | HIV-Associated Cryptococcal Meningitis | |
| Chairs: John Perfect, USA & Olivier Lortholary, France | ||
| 14:15 | S17.1 | Screening in Low-Resource Areas |
| Elvis Temfack, Cameroon | ||
| 14:35 | S17.2 | Current Therapeutic Strategies |
| Olivier Lortholary, France | ||
| 14:55 | S17.3 | Towards Having Antifungal Drugs in Low-Resource Areas |
| Ida Kolte, UK | ||
| 15:15 | S17.4 | Early versus Delayed Antiretroviral Treatment in HIV-Positive People with Cryptococcal Meningitis |
| Tihana Bicanic, FECMM, UK | ||
| 15:35 | S17.5 | Current and Future Clinical Trials on HIV-Associated Cryptococcal Meningitis |
| Tom Harrison, UK | ||
| Symposium 18 | Antifungal Stewardship in the Era of Resistance | |
| Chairs: Paul Verweij, FECMM, The Netherlands & Souha Kanj, FECMM Lebanon | ||
| 14:15 | S18.1 | Antifungal Stewardship: A Practical Experience in a Tertiary Care Institution |
| Maricela Valerio, Spain | ||
| 14:35 | S18.2 | Stewardship and Azole-Resistant Aspergillosis: A Challenge for Farmer or Physician? |
| Paul Verweij, FECMM, The Netherlands | ||
| 14:55 | S18.3 | Rapid Diagnosis of Fungal Infections: Impact on Stewardship |
| Souha Kanj, FECMM, Lebanon | ||
| 15:15 | S18.4 | Mycology Laboratory Diagnostic Capabilities in Different Areas of the World |
| Alessandro Pasqualotto, FECMM, Brazil | ||
| 15:35 | S18.5* | Optimising Antifungal Stewardship: An Evaluation of Candidaemia Guideline Compliance and Clinical Outcome |
| Laura Cottom, UK | ||
| Symposium 19 | Pneumocystis | |
| Chairs: Enrique Calderon, Spain & Stephane Bretagne, FECMM, France | ||
| 14:15 | S19.1 | Diagnosis |
| Alexandre Alanio, FECMM, France | ||
| 14:40 | S19.2 | Pneumocystosis in HIV and Non-HIV Patients |
| Joseph Kovacs, USA | ||
| 15:05 | S19.4 | Pneumocystosis in Neonates |
| Enrique Calderon, Spain | ||
| 15:30 | S19.5* | Evaluation of a Novel Commercial Loop-Mediated Isothermal Amplification (LAMP) Assay for Rapid Detection of Pneumocystis jirovecii |
| Dirk Schmidt, Germany | ||
| 16:15–17:45 | Parallel Symposia 20–24 | |
| Symposium 20 | Candida auris | |
| Chairs: Nelesh Govender, FECMM, South Africa & Anuradha Chowdhary, FECMM, India | ||
| 16:15 | S20.1 | Schizophrenic Gram-Negative Yeast Conquering the World |
| Jacques Meis, FECMM, The Netherlands | ||
| 16:35 | S20.2 | In the US |
| Tom Chiller, USA | ||
| 16:55 | S20.3 | Outbreak Control |
| Alba Ruiz, Spain | ||
| 17:15 | S20.4 | In Resource-Limited Countries |
| Anuradha Chowdhary, FECMM, India | ||
| 17:35 | S20.5* | Understanding Echinocandin Activity towards Candida auris |
| Milena Kordalewska, USA | ||
| Symposium 21 | Immunotherapy for Opportunistic Fungal Infections | |
| Chairs: Carol Garcia-Vidal, Spain & Dimitrios Kontoyiannis, FECMM, USA | ||
| 16:15 | S21.1 | CAR-T Cells, NK Cells |
| Dimitrios Kontoyiannis, FECMM, USA | ||
| 16:35 | S21.2 | WBC Transfusions |
| Livio Pagano, FECMM, Italy | ||
| 16:55 | S21.3 | Cytokines |
| George Chamilos, Greece | ||
| 17:15 | S21.4* | Novel Chimeric Antigen Receptor T Cells for Invasive Aspergillosis Immunotherapy |
| Michelle Seif, Germany | ||
| 17:25 | S21.5* | Comparison of Circulating Lymphocyte Populations CD4+ and CD8+ T Cells, B and NK lymphocytes According to the Favorable or Worsening Evolution of Patients with Pneumocystosis |
| Eléna Charpentier, France | ||
| 17:35 | S21.6* | Glucosylceramides from Lomentospora prolificans Induce Cytokines Production and Increase the Microbicidal Activity of Macrophages |
| Mariana Ingrid Dutra Silva Xisto, Brazil | ||
| Symposium 22 | NGS and Mycobiota | |
| Chairs: Laurence Delhaes, France & Jean-Pierre Gangneux, FECMM, France | ||
| 16:15 | S22.1 | Bacterial–Fungal Interactions at the Airway Mucosa and Implications for Chronic Rhinosinusitis |
| Emily Cope, USA | ||
| 16:35 | S22.2 | Respiratory Mycobiome—A Clinical Perspective |
| Robert Krause, FECMM, Austria | ||
| 16:55 | S22.3 | Characterization of Indoor Dust Microbiota in Homes of Asthma and Non-Asthma Patients |
| Jean-Pierre Gangneux, FECMM, France | ||
| 17:15 | S22.4 | Understanding the Role of the Gut Mycobiome in Health and Disease |
| Maria Vehreschild, FECMM, Germany | ||
| 17:35 | S22.5* | An ECMM-ESCMID Survey on Goals and Practices for Mycobiota Characterization Using Next-Generation Sequencing in European Laboratories |
| Jean-Pierre Gangneux, FECMM, France | ||
| Symposium 23 | The Funny Life of C. albicans in the Oral Tract | |
| Chairs: Marie-Elisabeth Bougnoux, France & Anna Maria Tortorano, Italy | ||
| 16:15 | S23.1 | Within-Host Genomic Diversity of Candida albicans in Healthy Carriers |
| Marie-Elisabeth Bougnoux, France | ||
| 16:35 | S23.2 | Activation of Oral Immune Responses by C. albicans |
| Julian Naglik, UK | ||
| 16:55 | S23.3 | Modulation of the Fungal–Host Interaction by the Intraspecies Diversity of C. albicans |
| Dominique Sanglard, Switzerland | ||
| 17:15 | S23.4 | Intestinal Th17 Drives Airway Inflammation in ABPA |
| Petra Bacher, Germany | ||
| 17:35 | S23.5* | Persistence of Clonal Azole-Resistant Isolates of Candida albicans from a Patient with Chronic Mucocutaneous Candidiasis in Colombia |
| Andres Ceballos-Garzon, Colombia | ||
| Symposium 24 | Fungal Neglected Tropical Diseases | |
| Chairs: Flavio Queiroz-Telles, Brazil & Leila Lopes Bezerra, Brazil | ||
| 16:15 | S24.1 | Mycetoma |
| Wendy van de Sande, FECMM, The Netherlands | ||
| 16:35 | S24.2 | Chromoblastomycosis |
| Flavio de Queiroz-Telles, FECMM, Brazil | ||
| 16:55 | S24.3 | Sporotrichosis |
| Leila Lopes Bezerra, Brazil | ||
| 17:15 | S24.4 | Novel Diagnostic and Treatment Strategies for the Southeast Asian Fungus Talaromyces marneffei |
| Thuy Le, USA | ||
| 17:25 | Discussion |